目的：筛选与大肠癌临床分期相关的蛋白，为大肠癌分子分期和预后预测提供依据。
Objective: to screen the associated proteins of clinical stage of colorectal carcinoma (CRC) in order to provide the basis of molecular biological stages and outcome prediction of CRC.
结论：不同临床分期的大肠癌中存在着差异表达蛋白，这些蛋白可能作为大肠癌分子分期和预后的标志物。
Conclusions: Differentail expressed proteins exist in different clinical stage of CRC, which would be as biomarkers for diagnosis and prediction of prognosis of CRC.
目的从分子水平对胃癌淋巴结微转移进行诊断分级，评价胃癌临床分期及预后。
Objective To evaluate clinical staging and prognosis of lymph nodes micrometastasis in gastric cancer from molecular level.
结论MTA1基因表达与宫颈癌临床分期及转移有关，可能预示宫颈癌的浸润转移的分子指标。
Conclusion MTA1 gene expression is associated with clinical stages and lymphatic metastasis of cervical cancer. It is a molecular index to predict invasion and metastasis of cervical cancer.
血浆EB病毒+DNA (EBV DNA)浓度是一项能反映鼻咽癌分期、治疗反应、预后的灵敏、特异的分子生物学指标。
Plasma Epstein-Barr virus DNA (EBV DNA) is a sensitive and specific molecular marker, which can reflect stage, response to treatment and prognosis of NPC.
血浆EB病毒+DNA (EBV DNA)浓度是一项能反映鼻咽癌分期、治疗反应、预后的灵敏、特异的分子生物学指标。
Plasma Epstein-Barr virus DNA (EBV DNA) is a sensitive and specific molecular marker, which can reflect stage, response to treatment and prognosis of NPC.
应用推荐